CORTAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cortan, and when can generic versions of Cortan launch?
Cortan is a drug marketed by Halsey and is included in one NDA.
The generic ingredient in CORTAN is prednisone. There are sixteen drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the prednisone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cortan
A generic version of CORTAN was approved as prednisone by WATSON LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CORTAN?
- What are the global sales for CORTAN?
- What is Average Wholesale Price for CORTAN?
Summary for CORTAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Clinical Trials: | 5 |
| Patent Applications: | 4,433 |
| DailyMed Link: | CORTAN at DailyMed |
Recent Clinical Trials for CORTAN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Weill Medical College of Cornell University | Phase 2 |
| Genentech, Inc. | Phase 2 |
| Massachusetts General Hospital | Phase 1 |
US Patents and Regulatory Information for CORTAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Halsey | CORTAN | prednisone | TABLET;ORAL | 087480-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
